[Clinical follow-up and genetic analysis of six cases with hypophosphatasia]

M Liu1, Y Zhao2, X J Liang1

  • 1Department of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.

Insights

Hypophosphatasia (HPP) in Chinese children shows varied outcomes. Infantile HPP has a poor prognosis, while childhood and odonto HPP cases improve with treatment. Genetic testing is key for diagnosis.

Area of Science:

  • Pediatrics
  • Genetics
  • Endocrinology

Background:

  • Hypophosphatasia (HPP) is a rare metabolic bone disease.
  • Clinical and genetic heterogeneity impacts HPP prognosis.
  • Understanding Chinese HPP patient characteristics is crucial.

Purpose of the Study:

  • To analyze clinical, genetic, and follow-up data of Chinese HPP patients.
  • To correlate genotype with phenotype and outcomes.
  • To evaluate diagnostic methods for HPP.

Main Methods:

  • Retrospective analysis of six pediatric HPP cases.
  • Clinical data collection and follow-up.
  • Genetic analysis of the ALPL gene in five patients.

Main Results:

  • Reduced serum alkaline phosphatase in all patients.
  • Diverse presentations: infantile, childhood, and odonto HPP.
  • Ten ALPL gene variations identified, including three novel ones.
  • Infantile HPP showed poor prognosis; childhood/odonto HPP improved with intervention.

Conclusions:

  • HPP prognosis varies significantly with age of onset.
  • Infantile HPP has a poor prognosis, while childhood/odonto HPP have better outcomes.
  • Genetic testing of the ALPL gene is essential for definitive HPP diagnosis.